At a glance
ClinicalIndex Comparison RecordPhase 1Completed
Drug / intervention
Neurovisiondevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Singapore Pilot Study To Evaluate The Efficacy Of A Computerized System For The Vision Improvement Of People With Low Myopia
In Brief
A Phase 1 clinical trial evaluating Neurovision for Myopia. Completed, across 1 site.
Detailed Summary
To assess how well and safe is Neurovision technology in improving the vision of people with low myopia in Singapore
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsMyopia
CountriesSingapore
CollaboratorsSingapore Eye Research Institute, NeuroVision
Timeline
Phase 1CompletedFinished
2003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartMar 2003
Primary CompletionOct 2004
First PostedJul 2006
TodayJul 2026
First PostedJul 4, 2006
Enrollment StartMar 1, 2003
Primary CompletionOct 1, 2004
TodayJul 2, 2026
Enrollment to primary: 1.6 yearsPosted 20.0 years ago
Interventions
Neurovisiondevice